Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Cannabinoid hyperemesis syndrome ( CHS ) has become more prevalent with increasing cannabis use. CHS is often resistant to standard antiemetics. The objective of this study is to review the current evidence for pharmacologic treatment of CHS . Medline , Psyc INFO , DARE , OpenGrey, Google Scholar, and the Cochrane Library were searched from inception to February 2017. Articles were selected and reviewed independently. Evidence was graded using Oxford Center for Evidence‐Based Medicine guidelines. The search resulted in 1262 articles with 63 of them eligible for inclusion (205 human subjects). There were 4 prospective level‐2, 3 retrospective level‐3 studies, 12 level‐4 case series, and 44 level‐5 case reports. Among level‐2 studies (64 subjects), tricyclic antidepressants ( TCA s) and lorazepam were discussed as effective long‐ and short‐term treatments, respectively, in two studies. Ondansetron, promethazine, diphenhydramine, and opioids were also mentioned, but the authors did not comment on their efficacy. Among level‐3 studies (43 subjects), one reported effective treatment with antiepileptics zonisamide and levetiracetam, but not TCA s. Another reported favorable response to morphine, ondansetron, and lorazepam but did not specify the actual number of patients receiving specific treatment. Among the level‐4 case series (54 subjects), benzodiazepines, haloperidol, and capsaicin were reported as helpful. For level‐5 case reports (44 subjects), benzodiazepines, metoclopramide, haloperidol, ondansetron, morphine, and capsaicin were reported as effective. Effective treatments mentioned only once included fentanyl, diazepam, promethazine, methadone, nabilone, levomepromazine, piritramide, and pantoprazole. Hot showers and baths were cited in all level‐4 and ‐5 articles as universally effective. High‐quality evidence for pharmacologic treatment of CHS is limited. Benzodiazepines, followed by haloperidol and capsaicin, were most frequently reported as effective for acute treatment, and TCA s for long‐term treatment. As the prevalence of CHS increases, future prospective trials are greatly needed to evaluate and further define optimal pharmacologic treatment of patients with CHS .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Namin, F., Patel, J., Lin, Z., Sarosiek, I., Foran, P., Esmaeili, P., & Mccallum, R. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00867.x · Cited by 129
Hejazi, R. A., Reddymasu, S. C., Namin, F., Lavenbarg, T., Foran, P., & McCallum, R. W. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181ac6489 · Cited by 84
Zonisamide or Levetiracetam for Adults With Cyclic Vomiting Syndrome: A Case Series
Clouse, R. E., Sayuk, G. S., Lustman, P. J., & Prakash, C. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.004 · Cited by 74
Cited by
Zhong, W., Shahbaz, O., Teskey, G., Beever, A., Kachour, N., Venketaraman, V., & Darmani, N. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115797 · Cited by 253
Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms
DeVuono, M. V., & Parker, L. A. (2020) · Cannabis & Cannabinoid Research · doi:10.1089/can.2019.0059 · Cited by 87
Andrews, C. N., Devlin, S. M., Le Foll, B., Fischer, B., Tse, F., Storr, M., & Congly, S. E. (2019) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwy064 · Cited by 25
“Small case series have suggested a possible benefit for intravenous haloperidol and topical capsaicin cream for acute exacerbations of CHS, with lesser apparent effectiveness of standard anti-emetic therapy, but no controlled trials have been performed (55, 57).”
BackgroundEuropean Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management
Malagelada, C., Keller, J., Sifrim, D., Serra, J., Tack, J., Mulak, A., Stengel, A., Aguilar, A., Drewes, A. M., Josefsson, A., et al. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.12711 · Cited by 8
Metadata
- Authors
- Richards, J. R., Gordon, B. K., Danielson, A. R., & Moulin, A. K.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2017-05-12
- Volume
- 37
- Issue
- 6
- Pages
- 725-734
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W2604246756
- Cited by
- 126
- References
- 3
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.